Join to View Full Profile
20 Acorn Park DriveCambridge, MA 02140
Phone+1 856-261-0153
Dr. Mookerjee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 1991 - 1994
ArMed Forces Medical College PuneClass of 1987
Certifications & Licensure
PA State Medical License 2001 - 2024
MD State Medical License 1994 - 2003
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
Clinical Trials
- Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation Start of enrollment: 2000 Oct 01
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Start of enrollment: 2000 Jan 01
- AZD2171 in Addition to Fulvestrant in Patients With Advanced Breast Cancer. Start of enrollment: 2007 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- 9 citationsCanakinumab in combination with docetaxel compared with docetaxel alone for the treatment of advanced non-small cell lung cancer following platinum-based doublet chemo...Luis Paz-Ares, Yasushi Goto, Darren Wan-Teck Lim, Balazs Halmos, Byoung Chul Cho
Lung Cancer. 2024-03-01 - 49 citationsLong-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials.Axel Hauschild, Paolo A. Ascierto, Dirk Schadendorf, Jean-Jacques Grob, Antoni Ribas
European Journal of Cancer. 2020-01-01 - 38 citationsDabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 ...G V Long, K T Flaherty, D Stroyakovskiy, H Gogas, E Levchenko
Annals of Oncology. 2019-11-01
Press Mentions
Two Combination Therapies Shrink Melanoma Brain Metastases in More Than Half of PatientsJune 4th, 2017
Professional Memberships
- Member
- European Society of Medical OncologyMember
Other Languages
- Bengali
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
